117 related articles for article (PubMed ID: 15028592)
1. I(1) imidazoline receptors involved in cardiovascular regulation: where are we and where are we going?
Bousquet P; Greney H; Bruban V; Schann S; Ehrhardt JD; Monassier L; Feldman J
Ann N Y Acad Sci; 2003 Dec; 1009():228-33. PubMed ID: 15028592
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of I1 imidazoline receptors: their role in blood pressure regulation.
Bousquet P
Am J Hypertens; 2000 Jun; 13(6 Pt 2):84S-88S. PubMed ID: 10921526
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of pyrrolinic isosteres of rilmenidine. Discovery of cis-/trans-dicyclopropylmethyl-(4,5-dimethyl-4,5-dihydro-3H-pyrrol-2-yl)-amine (LNP 509), an I1 imidazoline receptor selective ligand with hypotensive activity.
Schann S; Bruban V; Pompermayer K; Feldman J; Pfeiffer B; Renard P; Scalbert E; Bousquet P; Ehrhardt JD
J Med Chem; 2001 May; 44(10):1588-93. PubMed ID: 11334568
[TBL] [Abstract][Full Text] [Related]
4. I1 receptors, cardiovascular function, and metabolism.
Bousquet P
Am J Hypertens; 2001 Nov; 14(11 Pt 2):317S-321S. PubMed ID: 11721890
[TBL] [Abstract][Full Text] [Related]
5. Evidence for synergy between alpha(2)-adrenergic and nonadrenergic mechanisms in central blood pressure regulation.
Bruban V; Estato V; Schann S; Ehrhardt JD; Monassier L; Renard P; Scalbert E; Feldman J; Bousquet P
Circulation; 2002 Mar; 105(9):1116-21. PubMed ID: 11877365
[TBL] [Abstract][Full Text] [Related]
6. Respective contributions of alpha-adrenergic and non-adrenergic mechanisms in the hypotensive effect of imidazoline-like drugs.
Bruban V; Feldman J; Greney H; Dontenwill M; Schann S; Jarry C; Payard M; Boutin J; Scalbert E; Pfeiffer B; Renard P; Vanhoutte P; Bousquet P
Br J Pharmacol; 2001 May; 133(2):261-6. PubMed ID: 11350862
[TBL] [Abstract][Full Text] [Related]
7. Opposite to alpha2-adrenergic agonists, an imidazoline I1 selective compound does not influence reflex bradycardia in rabbits.
Sy GY; Bousquet P; Feldman J
Auton Neurosci; 2006 Jul; 128(1-2):19-24. PubMed ID: 16464646
[TBL] [Abstract][Full Text] [Related]
8. [Selectivity of a new antihypertensive agent, rilmenidine, for imidazoline receptors in the human brain].
Bricca G; Dontenwill M; Feldman J; Belcourt A; Bousquet P
Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1325-8. PubMed ID: 1979731
[TBL] [Abstract][Full Text] [Related]
9. Importance of imidazoline receptors in the cardiovascular actions of centrally acting antihypertensive agents.
Head GA
Ann N Y Acad Sci; 1995 Jul; 763():531-40. PubMed ID: 7677371
[TBL] [Abstract][Full Text] [Related]
10. Imidazoline receptors. A new concept in central regulation of the arterial blood pressure.
Bousquet P; Feldman J; Tibirica E; Bricca G; Greney H; Dontenwill M; Stutzmann J; Belcourt A
Am J Hypertens; 1992 Apr; 5(4 Pt 2):47S-50S. PubMed ID: 1350728
[TBL] [Abstract][Full Text] [Related]
11. Selectivity of rilmenidine for I1-imidazoline-binding sites in rabbit proximal tubule cells.
Gargalidis-Moudanos C; Parini A
J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S59-62. PubMed ID: 8642808
[TBL] [Abstract][Full Text] [Related]
12. Imidazoline receptors: a challenge.
Bousquet P; Bruban V; Schann S; Feldman J
Pharm Acta Helv; 2000 Mar; 74(2-3):205-9. PubMed ID: 10812959
[TBL] [Abstract][Full Text] [Related]
13. Imidazoline receptors in cardiovascular and metabolic diseases.
Bousquet P; Dontenwill M; Greney H; Feldman J
J Cardiovasc Pharmacol; 2000; 35(7 Suppl 4):S21-5. PubMed ID: 11346216
[TBL] [Abstract][Full Text] [Related]
14. Why imidazoline receptor modulator in the treatment of hypertension?
Schäfer SG; Kaan EC; Christen MO; Löw-Kröger A; Mest HJ; Molderings GJ
Ann N Y Acad Sci; 1995 Jul; 763():659-72. PubMed ID: 7677385
[TBL] [Abstract][Full Text] [Related]
15. Imidazoline antihypertensive drugs: selective i(1) -imidazoline receptors activation.
Nikolic K; Agbaba D
Cardiovasc Ther; 2012 Aug; 30(4):209-16. PubMed ID: 21884004
[TBL] [Abstract][Full Text] [Related]
16. I1-imidazoline receptors: an update.
Bousquet P; Dontenwill M; Greney H; Feldman J
J Hypertens Suppl; 1998 Aug; 16(3):S1-5. PubMed ID: 9747903
[TBL] [Abstract][Full Text] [Related]
17. Central imidazoline- and alpha 2-receptors involved in the cardiovascular actions of centrally acting antihypertensive agents.
Head GA
Ann N Y Acad Sci; 1999 Jun; 881():279-86. PubMed ID: 10415926
[TBL] [Abstract][Full Text] [Related]
18. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.
Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO
J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858
[TBL] [Abstract][Full Text] [Related]
19. Effects of centrally acting antihypertensive drugs on the microcirculation of spontaneously hypertensive rats.
Estato V; Araújo CV; Bousquet P; Tibiriçá E
Braz J Med Biol Res; 2004 Oct; 37(10):1541-9. PubMed ID: 15448876
[TBL] [Abstract][Full Text] [Related]
20. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension.
Wang X; Li G; Abdel-Rahman AA
Eur J Pharmacol; 2005 May; 514(2-3):191-9. PubMed ID: 15910806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
